IL23A, Human (Mirikizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-IL23A, Human (Mirikizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityIL23A, Human (Mirikizumab biosimilar)
CloneMirikizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human IL23A Recombinant Antibody (Mirikizumab). Mirikizumab (INN, development code LY3074828) is a human monoclonal antibody designed for the treatment of psoriasis. This drug was developed by Eli Lilly and Co. As of 2018, mirikizumab is undergoing Phase III trials.
Immunogenn/a
Other NamesAnti-IL23A Recombinant Antibody, Research Grade Mirikizumab, Anti-Human IL23A Recombinant Antibody(Mirikizumab), LY-3074828, Antibody Drug Analogues, Monoclonal Antibody, YR1481, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1884201-71-1
Catalog #YR1481
Priceplease inquire
Order / More InfoIL23A, Human (Mirikizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.